Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · IEX Real-Time Price · USD
3.260
+0.070 (2.19%)
At close: Apr 26, 2024, 4:00 PM
3.310
+0.050 (1.53%)
After-hours: Apr 26, 2024, 7:57 PM EDT

Abeona Therapeutics Revenue

In the year 2023, Abeona Therapeutics had annual revenue of $3.50M with 147.52% growth.

Revenue (ttm)
$3.50M
Revenue Growth
+147.52%
P/S Ratio
25.48
Revenue / Employee
$41,667
Employees
84
Market Cap
89.18M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.50M2.09M147.52%
Dec 31, 20221.41M-1.59M-52.87%
Dec 31, 20213.00M-7.00M-70.00%
Dec 31, 202010.00M--
Dec 31, 20190--
Dec 31, 20183.00M2.16M258.18%
Dec 31, 2017837.00K-52.00K-5.85%
Dec 31, 2016889.00K-151.00K-14.52%
Dec 31, 20151.04M115.00K12.43%
Dec 31, 2014925.00K-1.12M-54.70%
Dec 31, 20132.04M-2.36M-53.63%
Dec 31, 20124.40M2.54M135.63%
Dec 31, 20111.87M1.34M251.98%
Dec 31, 2010531.00K179.00K50.85%
Dec 31, 2009352.00K61.00K20.96%
Dec 31, 2008291.00K234.00K410.53%
Dec 31, 200757.00K--
Dec 31, 20060--
Dec 31, 20050--
Dec 31, 20040--
Dec 31, 20030--
Dec 31, 20021.15M904.00K372.02%
Dec 31, 2001243.00K136.00K127.10%
Dec 31, 2000107.00K92.00K613.33%
Dec 31, 199915.00K--
Dec 31, 19980--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetMed Express 276.97M
Assertio Holdings 152.07M
Protalix BioTherapeutics 65.49M
Allurion Technologies 53.47M
Gritstone bio 16.34M
Curis 10.02M
Atara Biotherapeutics 8.57M
Revenue Rankings